1. Home
  2. NLY vs ALGN Comparison

NLY vs ALGN Comparison

Compare NLY & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLY
  • ALGN
  • Stock Information
  • Founded
  • NLY 1996
  • ALGN 1997
  • Country
  • NLY United States
  • ALGN United States
  • Employees
  • NLY N/A
  • ALGN N/A
  • Industry
  • NLY Real Estate Investment Trusts
  • ALGN Industrial Specialties
  • Sector
  • NLY Real Estate
  • ALGN Health Care
  • Exchange
  • NLY Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • NLY 13.2B
  • ALGN 12.5B
  • IPO Year
  • NLY 1997
  • ALGN N/A
  • Fundamental
  • Price
  • NLY $20.54
  • ALGN $140.67
  • Analyst Decision
  • NLY Buy
  • ALGN Buy
  • Analyst Count
  • NLY 10
  • ALGN 13
  • Target Price
  • NLY $20.69
  • ALGN $216.25
  • AVG Volume (30 Days)
  • NLY 6.1M
  • ALGN 2.6M
  • Earning Date
  • NLY 07-23-2025
  • ALGN 07-30-2025
  • Dividend Yield
  • NLY 13.63%
  • ALGN N/A
  • EPS Growth
  • NLY N/A
  • ALGN 0.42
  • EPS
  • NLY 1.00
  • ALGN 5.92
  • Revenue
  • NLY $1,071,444,000.00
  • ALGN $3,964,802,000.00
  • Revenue This Year
  • NLY $337.55
  • ALGN $5.78
  • Revenue Next Year
  • NLY $2.00
  • ALGN $5.63
  • P/E Ratio
  • NLY $20.53
  • ALGN $23.75
  • Revenue Growth
  • NLY N/A
  • ALGN 0.56
  • 52 Week Low
  • NLY $16.60
  • ALGN $127.70
  • 52 Week High
  • NLY $22.11
  • ALGN $262.87
  • Technical
  • Relative Strength Index (RSI)
  • NLY 51.68
  • ALGN 35.24
  • Support Level
  • NLY $20.40
  • ALGN $142.00
  • Resistance Level
  • NLY $20.95
  • ALGN $149.01
  • Average True Range (ATR)
  • NLY 0.25
  • ALGN 4.60
  • MACD
  • NLY -0.04
  • ALGN 0.77
  • Stochastic Oscillator
  • NLY 22.88
  • ALGN 43.07

About NLY Annaly Capital Management Inc.

Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: